ClinicalTrials.gg
Sign In

Drug

PNU-100480 clinical trials

Also written PNU-100480 and Sutezolid.

studies test it
14
open now
2
in phase 3
1
first study started
2009

Keep track of what changes. Save the PNU-100480 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Period 1
7
Period 3
6

Development codes

PNU-100480
5

Other names

Sutezolid
4

Studies by the year they started

14 studies that test it; most in 2009 (2)

Studies that test PNU-100480, by start year
YearStudies
20092
20112
20132
20171
20181
20201
20211
20221
20231
20241
20251

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
4
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Tuberculosis
4
Tuberculosis, Pulmonary
3
Pulmonary Arterial Hypertension
1
Diabetes Mellitus, Type 2
1
Cardiomyopathies
1

Who runs them

Industry 9 · Other 5

Sequella, Inc. (3) · Pfizer (3) · The Aurum Institute NPC (1) · Indiana University (1) · Bial - Portela C S.A. (1) · Michael Hoelscher (1) · AJU Pharm Co., Ltd. (1) · Global Alliance for TB Drug Development (1)

Often tested with

Tested in the same studies.

Pretomanid (2) · Bedaquiline (2) · Linezolid (2) · Acetylcysteine (1) · Zamicastat (1) · Furosemide (1) · Palbociclib (1) · Rabeprazole (1)

Studies

Open first, then newest update. How each study uses PNU-100480 is read from its arms, and is right about nine times in ten.

Testing it · 14